Plasmapheresis in the treatment of patients with COVID-19

Phase 2

• Conditions: coronavirus disease (covid-19).; Coronavirus as the cause of diseases classified elsewhere; B97.2

• Registration Number: IRCT20180316039112N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

COVID-19

Exclusion Criteria

Patient dissatisfaction with inclusion in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified